Interventional Oncology Devices | Market Insights | US | 2021
Despite the short-term challenges posed by the COVID-19 pandemic, the US market for interventional oncology devices will grow modestly through 2029. This will be driven largely by the expanding treatable patient populations, an increasing shift towards higher-priced technologies, and growing physician acceptance of interventional oncology procedures. However, growth in this market will be hindered by mixed clinical data and a lack of reimbursement for newer technologies, which has led to a tempered adoption of interventional oncology devices.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for interventional oncology devices in the US across a 10-year period.
